ID

12357

Description

Study description: Study documentation part- Study termination. This is a phase II multicenter trial with Rivaroxaban in the treatment of livedoid vasculopathy assessing the pain on a visual analog scale (VAS). Principal Investigator PD Dr. Tobias Grge, University Hospital of Mnster. EudraCT - Nr. 2012-000108-13.

Mots-clés

  1. 11/11/2015 11/11/2015 -
Téléchargé le

11 novembre 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination DRKS00004652

Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination

Study termination
Description

Study termination

Alias
UMLS CUI-1
C0008972
UMLS CUI-2
C0013135
Date of termination:
Description

date

Type de données

date

Center number:
Description

Center number

Type de données

integer

Reasons for study termination
Description

Study termination; reason

Type de données

text

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0013135
UMLS CUI [1,3]
C1272707
Please mention the criteria, if inclusion or exclusion criteria is the reason for study drop out.
Description

inclusion criteria; exclusion criteria

Type de données

text

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251

Similar models

Riliva_CRF_EudraCT - Nr. 2012-000108-13-Study termination

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Study termination
C0008972 (UMLS CUI-1)
C0013135 (UMLS CUI-2)
date
Item
Date of termination:
date
Center number
Item
Center number:
integer
Item
Reasons for study termination
text
C0008972 (UMLS CUI [1,1])
C0013135 (UMLS CUI [1,2])
C1272707 (UMLS CUI [1,3])
Code List
Reasons for study termination
CL Item
Revocation of Consent by patient (1)
CL Item
Early ending of the entire study (2)
CL Item
Lack of patient compliance (3)
CL Item
Fall in hemoglobin of more than 2 units [g / dL] from initial value and source of bleeding can not be stopped (4)
CL Item
Decision of the investigator that further participation of the patient in the study is not justifiable (5)
CL Item
Violation of inclusion or exclusion criteria after 1st dose study medication (6)
inclusion criteria; exclusion criteria
Item
Please mention the criteria, if inclusion or exclusion criteria is the reason for study drop out.
text
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial